BLUE
bluebird bio
BLUE
BLUE
Delisted
BLUE was delisted on the 30th of May, 2025.
275 hedge funds and large institutions have $3.41B invested in bluebird bio in 2020 Q3 according to their latest regulatory filings, with 40 funds opening new positions, 100 increasing their positions, 84 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
275
Holders Change
-3
Holders Change %
-1.08%
% of All Funds
5.56%
Holding in Top 10
1
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-75%
% of All Funds
0.02%
New
40
Increased
100
Reduced
84
Closed
42
Calls
$55.7M
Puts
$54.3M
Net Calls
+$1.4M
Net Calls Change
+$7.91M
Top Buyers
1 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$18.4M |
2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$14.2M |
3 |
AC
Armistice Capital
New York
|
+$12.5M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.1M |
5 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$11.9M |